175 related articles for article (PubMed ID: 31848295)
41. Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.
Lemberg KM; Ali ES; Krecmerova M; Aguilar JMH; Alt J; Peters DE; Zhao L; Wu Y; Nuha N; Asara JM; Staedtke V; Pratilas CA; Majer P; Rais R; Ben-Sahra I; Slusher BS
Mol Cancer Ther; 2023 Dec; 22(12):1390-1403. PubMed ID: 37616542
[TBL] [Abstract][Full Text] [Related]
42. The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.
Neumann J; Boerries M; Köhler R; Giaisi M; Krammer PH; Busch H; Li-Weber M
Int J Cancer; 2014 Apr; 134(8):1991-2002. PubMed ID: 24150948
[TBL] [Abstract][Full Text] [Related]
43. Evidence for a functionally relevant rocaglamide binding site on the eIF4A-RNA complex.
Sadlish H; Galicia-Vazquez G; Paris CG; Aust T; Bhullar B; Chang L; Helliwell SB; Hoepfner D; Knapp B; Riedl R; Roggo S; Schuierer S; Studer C; Porco JA; Pelletier J; Movva NR
ACS Chem Biol; 2013 Jul; 8(7):1519-27. PubMed ID: 23614532
[TBL] [Abstract][Full Text] [Related]
44. Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.
Linke C; Wösle M; Harder A
BMC Cancer; 2020 Sep; 20(1):896. PubMed ID: 32948135
[TBL] [Abstract][Full Text] [Related]
45. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation.
Luan Z; He Y; He F; Chen Z
Mol Med Rep; 2015 Jan; 11(1):203-11. PubMed ID: 25333816
[TBL] [Abstract][Full Text] [Related]
46. Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumors.
Ghadimi MP; Lopez G; Torres KE; Belousov R; Young ED; Liu J; Brewer KJ; Hoffman A; Lusby K; Lazar AJ; Pollock RE; Lev D
Mol Cancer Ther; 2012 Aug; 11(8):1758-69. PubMed ID: 22848094
[TBL] [Abstract][Full Text] [Related]
47. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
[TBL] [Abstract][Full Text] [Related]
48. 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties.
Nilewski C; Michels TD; Packard GK; Xiang AX; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Ernst JT; Reich SH
Bioorg Med Chem Lett; 2021 Sep; 47():128111. PubMed ID: 34353608
[TBL] [Abstract][Full Text] [Related]
49. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo.
Jiang H; Zhao PJ; Su D; Feng J; Ma SL
Mol Med Rep; 2014 Jun; 9(6):2265-72. PubMed ID: 24718383
[TBL] [Abstract][Full Text] [Related]
50. WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth.
Thomson CS; Pundavela J; Perrino MR; Coover RA; Choi K; Chaney KE; Rizvi TA; Largaespada DA; Ratner N
Oncogene; 2021 Jun; 40(24):4229-4241. PubMed ID: 34079083
[TBL] [Abstract][Full Text] [Related]
51. Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.
Johansson G; Mahller YY; Collins MH; Kim MO; Nobukuni T; Perentesis J; Cripe TP; Lane HA; Kozma SC; Thomas G; Ratner N
Mol Cancer Ther; 2008 May; 7(5):1237-45. PubMed ID: 18483311
[TBL] [Abstract][Full Text] [Related]
52. New rocaglamide derivatives from Vietnamese Aglaia species.
Duong NT; Edrada-Ebel R; Ebel R; Lin W; Duong AT; Dang XQ; Nguyen NH; Proksch P
Nat Prod Commun; 2014 Jun; 9(6):833-4. PubMed ID: 25115092
[TBL] [Abstract][Full Text] [Related]
53. The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA.
Iwasaki S; Iwasaki W; Takahashi M; Sakamoto A; Watanabe C; Shichino Y; Floor SN; Fujiwara K; Mito M; Dodo K; Sodeoka M; Imataka H; Honma T; Fukuzawa K; Ito T; Ingolia NT
Mol Cell; 2019 Feb; 73(4):738-748.e9. PubMed ID: 30595437
[TBL] [Abstract][Full Text] [Related]
54. Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia.
Alachkar H; Santhanam R; Harb JG; Lucas DM; Oaks JJ; Hickey CJ; Pan L; Kinghorn AD; Caligiuri MA; Perrotti D; Byrd JC; Garzon R; Grever MR; Marcucci G
J Hematol Oncol; 2013 Mar; 6():21. PubMed ID: 23497456
[TBL] [Abstract][Full Text] [Related]
55. Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor.
Li XX; Zhang SJ; Chiu AP; Lo LH; Huang J; Rowlands DK; Wang J; Keng VW
Cancer Med; 2018 Sep; 7(9):4791-4800. PubMed ID: 30112810
[TBL] [Abstract][Full Text] [Related]
56.
Oppel F; Ki DH; Zimmerman MW; Ross KN; Tao T; Shi H; He S; Aster JC; Look AT
Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32651197
[TBL] [Abstract][Full Text] [Related]
57. ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study.
Geller JI; Pressey JG; Smith MA; Kudgus RA; Cajaiba M; Reid JM; Hall D; Barkauskas DA; Voss SD; Cho SY; Berg SL; Dome JS; Fox E; Weigel BJ
Cancer; 2020 Dec; 126(24):5303-5310. PubMed ID: 32914879
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of Wnt3a/FOXM1/β-Catenin Axis and Activation of GSK3β and Caspases are Critically Involved in Apoptotic Effect of Moracin D in Breast Cancers.
Hwang SM; Lee HJ; Jung JH; Sim DY; Hwang J; Park JE; Shim BS; Kim SH
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201862
[TBL] [Abstract][Full Text] [Related]
59. Cyclopenta[b]benzofuran and Secodammarane Derivatives from the Stems of Aglaia stellatopilosa.
Othman N; Pan L; Mejin M; Voong JC; Chai HB; Pannell CM; Kinghorn AD; Yeo TC
J Nat Prod; 2016 Apr; 79(4):784-91. PubMed ID: 26974604
[TBL] [Abstract][Full Text] [Related]
60. HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST).
Lopez G; Bill KL; Bid HK; Braggio D; Constantino D; Prudner B; Zewdu A; Batte K; Lev D; Pollock RE
PLoS One; 2015; 10(7):e0133302. PubMed ID: 26200462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
